OBJECTIVE: To evaluate the efficacy and safety of an alpha-lactalbumin-enriched formula with a protein profile and total protein concentration closer to human milk (HM) and lower than conventional formulas. SUBJECTS/ METHODS: Two hundred and sixteen healthy, term infants, <or=14 days post-natal age were enrolled and 166 (76.9%) completed the study. Timed post-prandial plasma essential amino-acid levels were determined after 8 weeks of ad libitum study feeding. Study events were assessed every 2 weeks. RESULTS: At 8 weeks, all mean plasma essential amino-acid levels in the experimental formula (EF) group were as high as the standard formula (SF) and HM groups. The incidence of feeding-related gastrointestinal (GI) events varied significantly (P=0.025) across groups: SF (31.3%), EF (17.2%) and HM (13.6%), with SF being significantly higher than HM (P=0.015). Study withdrawals due to feeding-related GI events were significantly different (P=0.001) across groups: SF (12.5%), EF (4.7%), and HM (0%). The timing of GI events was also significantly different across groups (P=0.010). CONCLUSION: The study demonstrated that feeding a higher quality, lower protein concentration formula (alpha-lactalbumin-enriched) met all essential amino acid and protein requirements of infants. The GI tolerance profile of infants receiving the EF was similar to HM-fed infants.
RCT Entities:
OBJECTIVE: To evaluate the efficacy and safety of an alpha-lactalbumin-enriched formula with a protein profile and total protein concentration closer to human milk (HM) and lower than conventional formulas. SUBJECTS/ METHODS: Two hundred and sixteen healthy, term infants, <or=14 days post-natal age were enrolled and 166 (76.9%) completed the study. Timed post-prandial plasma essential amino-acid levels were determined after 8 weeks of ad libitum study feeding. Study events were assessed every 2 weeks. RESULTS: At 8 weeks, all mean plasma essential amino-acid levels in the experimental formula (EF) group were as high as the standard formula (SF) and HM groups. The incidence of feeding-related gastrointestinal (GI) events varied significantly (P=0.025) across groups: SF (31.3%), EF (17.2%) and HM (13.6%), with SF being significantly higher than HM (P=0.015). Study withdrawals due to feeding-related GI events were significantly different (P=0.001) across groups: SF (12.5%), EF (4.7%), and HM (0%). The timing of GI events was also significantly different across groups (P=0.010). CONCLUSION: The study demonstrated that feeding a higher quality, lower protein concentration formula (alpha-lactalbumin-enriched) met all essential amino acid and protein requirements of infants. The GI tolerance profile of infants receiving the EF was similar to HM-fed infants.
Authors: J Trabulsi; R Capeding; J Lebumfacil; K Ramanujam; P Feng; S McSweeney; B Harris; P DeRusso Journal: Eur J Clin Nutr Date: 2010-11-10 Impact factor: 4.016
Authors: Lorena G Oropeza-Ceja; Jorge L Rosado; Dolores Ronquillo; Olga P García; María Del C Caamaño; Carlos García-Ugalde; Rubí Viveros-Contreras; Miguel Ángel Duarte-Vázquez Journal: Nutrients Date: 2018-07-10 Impact factor: 5.717
Authors: Charlotte Holme Nielsen; Yan Hui; Duc Ninh Nguyen; Agnethe May Ahnfeldt; Douglas G Burrin; Bolette Hartmann; Anne Birgitte Heckmann; Per Torp Sangild; Thomas Thymann; Stine Brandt Bering Journal: Nutrients Date: 2020-01-17 Impact factor: 5.717